undamentalytics Newsletter

Collis Steven H: insider trades

Chief executive, Officer, Director at 3 companies we cover. 2 open-market purchases and 45 sales not made under a pre-set plan, reported from February 2, 2010 to March 6, 2026.

Would copying Collis Steven H’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 25, 2026 into $12,336 by November 2, 2026, +35.8% a year. The copy held shares only 100% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $10,999, +14.9% a year (the S&P 500 held throughout made $10,999, +14.9% a year). Beta against the index was 0.51. After their sales, the shares moved −8.3% against the index over 12 months on average (a negative figure means selling was the right call); 76% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k 2026 $12.3k$11.0k$11.0k
Copying Collis Steven HS&P 500, same days investedS&P 500, held throughout $10,000 copying Collis Steven H’s open-market purchases from February 25, 2026, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+35.8%
S&P 500, same days invested
+14.9% (held throughout +14.9%)
Time in shares
100%
Sharpe ratio (S&P 500)
1.24 (0.82)
Biggest drop (S&P 500)
−11% (−9%)
Market sensitivity (beta)
0.51
Purchases copied
2

Trade by trade

Collis Steven H: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 +8.3% +8.3% 50% 1 — — Not enough years
Purchases, 6 months after the report 2 +6.4% +6.4% 50% 1 — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 45 −2.4% −1.7% 58% 13 0.28 0.78 No reliable evidence
Sales, 12 months after the report 45 −8.3% −9.4% 76% 13 0.69 0.50 No reliable evidence
Sales, 12 months after the trade 45 −7.8% −11.8% 73% 13 0.82 0.43 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cencora COR Executive Chairman045February 2, 2010November 26, 2024
Bausch & Lomb Corp BLCO —10February 24, 2026February 24, 2026
Elevance Health ELV —10March 6, 2026March 6, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 6, 2026March 5, 2026 ELV Purchase $869,520 +40.6%not yetnot yet
February 24, 2026February 23, 2026 BLCO Purchase $267,150 −24.0%not yetnot yet
November 26, 2024November 25, 2024 COR Sale $12,199,000 +5.0%+26.3%+36.5%
December 15, 2023December 13, 2023 COR Sale $8,713,374 +10.5%−10.9%−15.1%
December 14, 2022December 12, 2022 COR Sale $13,083,695 −8.7%−1.4%+3.4%
February 11, 2021February 10, 2021 COR Sale $153,366 +5.9%+27.5%+23.7%
February 9, 2021February 5, 2021 COR Sale $9,341,888 +10.4%+23.7%+14.7%
June 20, 2019June 19, 2019 COR Sale $9,292,445 +0.8%+22.4%+17.4%
March 4, 2019March 1, 2019 COR Sale $1,784,785 +4.3%+8.3%+1.2%
February 5, 2019February 1, 2019 COR Sale $1,723,372 −13.3%−9.4%−11.7%
January 3, 2019January 2, 2019 COR Sale $1,579,046 −8.7%−6.5%−8.8%
December 4, 2018December 3, 2018 COR Sale $1,898,442 −12.7%−9.7%−8.0%
November 5, 2018November 1, 2018 COR Sale $1,941,142 +1.9%−7.6%−12.1%
October 2, 2018October 1, 2018 COR Sale $1,987,472 −5.1%−7.1%−7.7%
September 5, 2018September 4, 2018 COR Sale $1,885,846 +3.7%−2.1%−3.5%
August 2, 2018August 1, 2018 COR Sale $1,734,688 +15.9%+5.5%+13.1%
July 3, 2018July 2, 2018 COR Sale $1,806,850 −2.4%−5.2%−4.9%
June 4, 2018June 1, 2018 COR Sale $1,773,758 −0.2%−5.9%−2.6%
May 2, 2018May 1, 2018 COR Sale $1,889,262 −15.1%−18.9%−22.8%
April 3, 2018April 2, 2018 COR Sale $1,794,040 −2.3%−20.1%−20.2%
March 2, 2018March 1, 2018 COR Sale $2,012,238 −12.2%−21.6%−18.5%
February 2, 2018February 1, 2018 COR Sale $2,104,683 −9.0%−9.4%−11.9%
January 3, 2018January 2, 2018 COR Sale $1,997,079 −5.0%−14.7%−13.2%
September 5, 2017September 1, 2017 COR Sale $1,198,800 −0.2%−7.5%−6.0%
July 5, 2017July 3, 2017 COR Sale $1,421,400 −15.9%−19.9%−20.8%
June 2, 2017June 1, 2017 COR Sale $1,375,950 −15.7%−22.4%−23.5%
May 2, 2017May 1, 2017 COR Sale $1,229,700 +6.6%−7.1%−3.1%
April 4, 2017April 3, 2017 COR Sale $1,325,250 +3.6%−13.0%−13.6%
December 2, 2016December 1, 2016 COR Sale $1,169,100 +4.8%−11.6%−11.8%
November 2, 2016November 1, 2016 COR Sale $1,047,750 +14.7%−21.0%−12.8%
October 18, 2016October 17, 2016 COR Sale $1,193,850 −1.7%−17.7%−20.7%
August 9, 2016August 5, 2016 COR Sale $12,149,625 −20.0%−23.0%−24.2%
December 22, 2015December 21, 2015 COR Sale $2,775,340 −15.6%−35.6%−36.3%
December 9, 2015December 7, 2015 COR Sale $917,508 −12.3%−33.7%−28.5%
December 7, 2015December 4, 2015 COR Sale $1,800,856 −10.9%−33.5%−26.7%
November 19, 2015November 18, 2015 COR Sale $2,598,952 −4.6%−26.9%−25.9%
October 29, 2015October 27, 2015 COR Sale $121,164 −0.4%−30.4%−23.0%
September 22, 2015September 21, 2015 COR Sale $2,870,087 −5.1%−32.0%−31.8%
August 21, 2015August 20, 2015 COR Sale $2,830,722 −10.1%−26.3%−22.2%
July 22, 2015July 20, 2015 COR Sale $3,106,274 −12.1%−26.5%−27.9%
June 23, 2015June 22, 2015 COR Sale $3,050,621 +1.6%−30.5%−31.0%
February 5, 2015February 4, 2015 COR Sale $13,981,168 +15.8%−4.9%−6.8%
June 13, 2014June 11, 2014 COR Sale $11,313,225 +4.9%+47.0%+44.6%
November 5, 2013November 5, 2013 COR Sale $10,080,000 −2.5%+15.0%+16.1%
May 2, 2013May 1, 2013 COR Sale $13,343,250 +1.1%+1.9%+0.8%
March 22, 2012March 21, 2012 COR Sale $9,476,769 +1.6%+18.0%+20.4%
February 2, 2010January 29, 2010 COR Sale $3,929,509 +3.1%+5.7%+12.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Collis Steven H traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.